Willan, Andrew R.; Goeree, Ron; Pullenayegum, Eleanor M.; … - In: PharmacoEconomics 24 (2006) 1, pp. 93-106
this report is the economic evaluation based on these data. Objective: To determine the cost effectiveness of rivastigmine … diagnosis of Parkinson's disease. Methods: A cost-effectiveness analysis was performed by applying Canadian and UK cost weights …, there was an observed increase in cost in the rivastigmine arm of $Can55.76 (two-sided p-value 0.98 [90% CI -3431, 3543 …